loadpatents
Patent applications and USPTO patent grants for Asclepiumm Taiwan Co., Ltd.The latest application filed is for "dsg2 monoclonal antibody and the applications thereof".
Patent | Date |
---|---|
DSG2-derived peptides Grant 11,021,526 - Chen , et al. June 1, 2 | 2021-06-01 |
Dsg2 monoclonal antibody and the applications thereof Grant 10,836,823 - Chen , et al. November 17, 2 | 2020-11-17 |
Antibody Fusion Proteins For Drug Delivery App 20190298848 - CHEN; Min-che ;   et al. | 2019-10-03 |
Dsg2 Monoclonal Antibody And The Applications Thereof App 20190300604 - CHEN; Min-che ;   et al. | 2019-10-03 |
Dsg2-derived Peptides App 20190177394 - CHEN; Min-che ;   et al. | 2019-06-13 |
Use of peptide for treating angiogenesis-related diseases Grant 9,925,238 - Lu , et al. March 27, 2 | 2018-03-27 |
Use Of Peptide For Treating Angiogenesis-related Diseases App 20170042970 - LU; Chi-Sheng ;   et al. | 2017-02-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.